A post hoc analysisof GISSI-HF trial (21) indicated that per 1SD increase in baseline plasma adiponectin level was independently associated withincreased mortality (hazard ratio 1.24; 95%CI 1.12–1.37). This evidence concerns the gene ADIPOQ and hydrops fetalis.